|
|
 |
Registry Of Lobbyists - Sean D. Awalt
|
|
| Registration Number | Status | | | 1805 | Terminated | | | Initial registration date | Last date of any changes | | 24-September-2018 | 18-October-2019 |
|
Lobbyist's Last Name
Awalt |
Lobbyist's First Name
Sean |
Middle Initial
D. |
|
Business Address of Lobbyist
16750 Trans Canada Hwy. |
City
Kirkland |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H9H 4M7 |
Telephone
902-877-4587 |
Fax
|
| |
Business or Firm Name for Lobbyist (if applicable)
Merck Canada Inc. |
Registry of Joint Stock Companies Number
|
Business Address of Lobbyist's Business or Firm
16750 Trans Canada Hwy. |
City
Kirkland |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H9H 4M7 |
Telephone
902-877-4587 |
Fax
|
|
|
Lobbying on behalf of (Name of Client)
Merck Canada Inc. |
Business Address
16750 Trans Canada Hwy. |
City
Kirkland |
Province/State
PQ |
Country
CA |
Postal/Zip Code
H9H 4M7 |
Telephone
902-877-4587 |
Fax
|
| |
|
|
|
No other beneficiaries of lobbying activities
|
|
| I. Description |
•To support the Life Sciences Sector and importance of innovation for progressive economic development.
•To support the value of innovative medicines and early access to optimize health care delivery by health care professionals and health outcomes for patients.
•To support the value of biosimilars and recognize the opportunity transition policies enable for cost savings within drug budgets creating budget headroom for healthcare priorities.
|
II. Subject Matter
|
|
|
| |
III. Lobby Targets
|
| Economic Development |
Finance |
| Health |
NS Business Inc. |
| Treasury and Policy Board |
|
|
| |
IV. Communication Techniques
|
| Arranging one or more meetings |
Meetings |
| Presentations |
Written communication (hard copy or electronic) |
| Telephone calls |
Grass-roots communication |
| Informal communications |
|
|
| |
V. Have you lobbied, or do you expect to lobby, a member of the House of Assembly in the member's capacity as a member, Or a person on the member's staff?
yes
|
|
|
No funding from any government or agency
|
|
No private funding related to lobbying activities
|
|
Payment is not contingent, in whole or in part, on the success of the undertaking.
|
|
|
